US-based contract drug development firm Aptuit is acquiring a majority stake in Hyderabad-based Laurus Labs by putting in more than $100 million (above Rs 400 crore) over the next four years.
Following the agreement, the two companies announced the formation a new entity called Aptuit Laurus.
Laurus Labs, a start-up company, is a knowledge resource and solutions provider with a research and development center near Hyderabad and a manufacturing plant in Visakhapatnam, which is currently under construction.
(Source: Business Standard)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment